BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 20385507)

  • 1. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
    Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG;
    Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft.
    El-Chami MF; Kilgo P; Thourani V; Lattouf OM; Delurgio DB; Guyton RA; Leon AR; Puskas JD
    J Am Coll Cardiol; 2010 Mar; 55(13):1370-6. PubMed ID: 20338499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.
    Ruff CT; Bhatt DL; Steg PG; Gersh BJ; Alberts MJ; Hoffman EB; Ohman EM; Eagle KA; Lip GY; Goto S;
    Int J Cardiol; 2014 Jan; 170(3):413-8. PubMed ID: 24321327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry.
    Barba R; Bisbe J; Pedrajas JN; Toril J; Monte R; Muñoz-Torrero JF; Monreal M;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):457-63. PubMed ID: 19369873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].
    Guize L; Thomas F; Bean K; Benetos A; Pannier B
    Bull Acad Natl Med; 2007; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease.
    Feringa HH; Karagiannis SE; Schouten O; Vidakovic R; van Waning VH; Boersma E; Welten G; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):206-13. PubMed ID: 17481930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative cardiac risk index predicts long-term mortality and health status.
    Hoeks SE; op Reimer WJ; van Gestel YR; Smolderen KG; Verhagen H; van Domburg RT; van Urk H; Poldermans D
    Am J Med; 2009 Jun; 122(6):559-65. PubMed ID: 19376487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality.
    Ahlsson A; Bodin L; Fengsrud E; Englund A
    Scand Cardiovasc J; 2009; 43(5):330-6. PubMed ID: 19137475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study).
    Bilato C; Corti MC; Baggio G; Rampazzo D; Cutolo A; Iliceto S; Crepaldi G
    Am J Cardiol; 2009 Oct; 104(8):1092-7. PubMed ID: 19801031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
    Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.